Guselkumab vs placebo
Proportion of participants achieving a 50% reduction in disease severity · chronic palmoplantar pustulosis
Guselkumab probably leads to higher proportion of participants achieving a 50% reduction in disease… compared with placebo (moderate certainty).
1 finding from 1 review
- RR 2.88 [1.24, 6.69]1 study · 49 participantsModerate